Donate
Australian & New Zealand Childrens Haematology/Oncology Group

ANZCHOG Children’s Cancer Clinical Trials Repository

Study Title
An Overarching Study for Children and Adults With Frontline and Relapsed RhabdoMyoSarcoma
Protocol ID
RG_17-427 (FAR-RMS)
Disease (Sub Disease)
Rhabdomyosarcoma
Diagnosis Stage
Relapsed/ refractory
Location
VIC, NZ
Sponsor
Australian and New Zealand Children's Haematology Oncology Group
University of Birmingham
Trial Status
Open
Sites
Royal Children's Hospital
Christchurch Hospital
Study Type
Treatment
Phase
Phase 1
Age Eligibility
no limits
International registry ID's
NCT04625907
Back to Registry
Study Title An Overarching Study for Children and Adults With Frontline and Relapsed RhabdoMyoSarcoma
Protocol ID RG_17-427 (FAR-RMS)
Disease (Sub Disease) Rhabdomyosarcoma
Diagnosis Stage Relapsed/ refractory
Location VIC / NZ
Sponsor Australian and New Zealand Children's Haematology Oncology Group/ University of Birmingham
Links https://clinicaltrials.gov/ct2/show/NCT04625907
Trial Status Open
Trial Open Date 17/09/2020
Sites Royal Children's Hospital / Christchurch Hospital
Study Type Treatment
Phase Phase 1
Age Eligibility no limits
International registry ID's NCT04625907